Thermal Measurements of the Gut With a Colonoscope Compatible Thermal Probe
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Massachusetts General Hospital
- Study ID
- NCT07352995
- Status
- Enrolling By Invitation
Conditions
- Crohn Disease
- Inflammatory Bowel Diseases
- Ulcerative Colitis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Feasibility of using a thermal probe to measure temperature rise in colonic mucosa — DEVICE10 participants in each arm will be enrolled in this study. All consented participants will receive the same intervention.
Study Details
The goal of this clinical trial is to use a modified thermal probe to measure temperature rise in the colonic mucosa of participants with inflammatory bowel disease, Crohn's disease, and/or ulcerative colitis. The main question it aims to answer is: Is the thermal probe an effective device to use to detect temperature rise in the colonic mucosa? During the participant's standard of care colonoscopy, the thermal probe will be inserted into the colonoscope. The thermal probe is connected to a temperature transmitter that collects and saves the temperature of the colon in real time.
Key Dates
- Start date
- Mar 25, 2026
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2028
- Completion
- Dec 31, 2029
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DEVICE_FEASIBILITY
Arms
- Experimental: IBD, Crohn's Disease, and/or UC10 adult participants currently diagnosed with inflammatory bowel disease (IBD), Crohn's disease, and/or ulcerative colitis (UC) will be enrolled at MGH
- Experimental: Undergoing Colorectal Screening10 adult subjects undergoing colorectal cancer screening will be enrolled at MGH
Primary Outcome Measure
Ability of thermal probe to collect temperature measurements from colonic mucosa [ Time Frame: Thermal measurements are collected during the study procedure and analyzed within one year of collection. ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | - |
Find similar trials in Boston, MA
Related Studies
- CorEvitas Inflammatory Bowel Disease (IBD) RegistryEnrolling By Invitation · CorEvitas · Waltham, Massachusetts
- Precision Diagnostics in Inflammatory Bowel Disease, Cellular Therapy and Transplantation (The PREDICT Trial)Enrolling By Invitation · Boston Children's Hospital · Boston, Massachusetts
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Low Dose IL-2 for the Treatment of Crohn's DiseasePHASE1/PHASE2 · Recruiting · Boston Children's Hospital · Boston, Massachusetts